Vi dækker
ESMO I European Society for Medical Oncology
ESMO 2024
PD-1 Inhibitors Have Shown Remarkable Efficacy
- / BestPractice Nordic
Highlights fra ESMO 2024
Highlights: Det kliniske landskab for brystkræft efter ESMO 2024
/ Louise Wichmann Matthiessen
Top 4 mest sete MEDtalks fra ESMO 2024
Mere fra ESMO 2024
Abstracts fra ESMO 2024
Gastrointestinal Cancer: 14 Years to Reach the Final Conclusion
- / BestPractice Nordic
ESMO 2023
ESMO 2023 • Meet the experts
Optimizing PARP Inhibitor Therapy for Ovarian Cancer
/ Mansoor Raza Mirza
Enabling Patient Empowerment Through Digital Monitoring
/ Ellinor Christin Haukland